GE HealthCare (Nasdaq:GEHC) announced today that it submitted its CleaRecon DL technology for FDA 510(k) clearance.

GE HealthCare Technologies Inc. GEHC recently announced the 510(k) submission to the FDA for CleaRecon DL, a deep-learning ...

“Over the years, artifacts created in scans through natural movement of the body and the distribution of contrast have posed another significant challenge to clinicians when obtaining CBCT ...